| pubmed-article:2261738 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2261738 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:2261738 | lifeskim:mentions | umls-concept:C0007301 | lld:lifeskim |
| pubmed-article:2261738 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:2261738 | lifeskim:mentions | umls-concept:C0439855 | lld:lifeskim |
| pubmed-article:2261738 | lifeskim:mentions | umls-concept:C0243102 | lld:lifeskim |
| pubmed-article:2261738 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:2261738 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2261738 | pubmed:dateCreated | 1991-2-7 | lld:pubmed |
| pubmed-article:2261738 | pubmed:abstractText | The in vitro collagenolytic and proteoglycanasic activity from human fibrillated osteoarthritic cartilage was determined using labelled proteoglycans and type II collagen as substrates. In vitro, a glycosaminoglycan-peptide complex (GP-C Rumalon) induced a dose-dependent inhibition of both collagenolytic and proteoglycanasic activities while sodium salicylate and indomethacin had only a weak suppressive effect on proteoglycanase. Phospholipase A2 activity was unmodified by GP-C suggesting that the effect of the drug on degradative enzymes was unrelated to prostaglandin formation. | lld:pubmed |
| pubmed-article:2261738 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2261738 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2261738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2261738 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2261738 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:2261738 | pubmed:issn | 0770-3198 | lld:pubmed |
| pubmed-article:2261738 | pubmed:author | pubmed-author:LouisotPP | lld:pubmed |
| pubmed-article:2261738 | pubmed:author | pubmed-author:MartinAA | lld:pubmed |
| pubmed-article:2261738 | pubmed:author | pubmed-author:RichardMM | lld:pubmed |
| pubmed-article:2261738 | pubmed:author | pubmed-author:MathieuPP | lld:pubmed |
| pubmed-article:2261738 | pubmed:author | pubmed-author:VignonEE | lld:pubmed |
| pubmed-article:2261738 | pubmed:author | pubmed-author:ConrozierTT | lld:pubmed |
| pubmed-article:2261738 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2261738 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:2261738 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2261738 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2261738 | pubmed:pagination | 383-8 | lld:pubmed |
| pubmed-article:2261738 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:meshHeading | pubmed-meshheading:2261738-... | lld:pubmed |
| pubmed-article:2261738 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2261738 | pubmed:articleTitle | Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage. | lld:pubmed |
| pubmed-article:2261738 | pubmed:affiliation | Laboratoire d'Exploration Articulaire, Hôpital Edouard Herriot, Lyon, France. | lld:pubmed |
| pubmed-article:2261738 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2261738 | lld:pubmed |
